Anli Yang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Circular RNAs in diseases 10
- RNA modifications and cancer 7
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 11
- Breast Cancer Treatment Studies 5
- Co-authors
- Yutian Zou (15 shared papers)Shaoquan Zheng (15 shared papers)Hailin Tang (16 shared papers)Weikai Xiao (16 shared papers)Xiaoming Xie (8 shared papers)Xiaoming Xie (6 shared papers)Xinhua Xie (8 shared papers)Jie‐Ying Liang (6 shared papers)
- Journals
- Frontiers in Immunology (2 papers)BMC Cancer (2 papers)Annals of Oncology (2 papers)Aging (2 papers)Journal of Cellular and Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Anli Yang
66 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 780
- Oncology 381
- Molecular Biology 917
- Pulmonary and Respiratory Medicine 325
- Hepatology 55
Countries citing papers authored by Anli Yang
This map shows the geographic impact of Anli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anli Yang more than expected).
Fields of papers citing papers by Anli Yang
This network shows the impact of papers produced by Anli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anli Yang. The network helps show where Anli Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Anli Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 121 | |
| 2 | 2019 | 100 | |
| 3 | 2020 | 88 | |
| 4 | 2019 | 72 | |
| 5 | 2014 | 72 | |
| 6 | 2019 | 66 | |
| 7 | 2020 | 65 | |
| 8 | 2018 | 62 | |
| 9 | 2021 | 58 | |
| 10 | 2020 | 57 | |
| 11 | 2020 | 49 | |
| 12 | 2022 | 47 | |
| 13 | 2020 | 43 | |
| 14 | 2020 | 43 | |
| 15 | 2024 | 42 | |
| 16 | 2023 | 42 | |
| 17 | 2020 | 39 | |
| 18 | 2013 | 38 | |
| 19 | 2020 | 34 | |
| 20 | 2019 | 32 |
About Anli Yang
Anli Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 71 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (10 papers), Nanoplatforms for cancer theranostics (7 papers), RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Cancer Research (780 citations), Oncology (381 citations), Molecular Biology (917 citations), Pulmonary and Respiratory Medicine (325 citations) and Hepatology (55 citations). Anli Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yutian Zou, Shaoquan Zheng, Hailin Tang, Weikai Xiao, Xiaoming Xie, Xiaoming Xie, Xinhua Xie, Jie‐Ying Liang, Yanan Kong and Feng Cai. Their work appears in journals such as Frontiers in Immunology, BMC Cancer, Annals of Oncology, Aging and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.